EUVIMEDEUVIMED entdecken
Crossref

PCDHGA10 as a Potential Biomarker of Lung Squamous Cell Carcinoma Based on Bioinformatics and Experimental Verification

Shuming Song, Ruijiao Lu, Yuanya Chen, Yangchun Feng

Molecular Biotechnology · 2025

DOI: 10.1007/s12033-024-01178-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Shuming Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: Xinjiang Key Laboratory of Oncology, Cancer Hospial Affiliated to Xinjiang Medical University, Urumqi, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Biomarkers, Tumor, Carcinoma, Squamous Cell, Cadherins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Xinjiang Uygur Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Procalcitonin gamma subfamily A, 10 (PCDHGA10) is a member of the procalcitonin gamma gene cluster, which is associated with neuronal synapse development. However, there are lack of studies on the role and potential prognostic value of PCDHGA10 in lung squamous cell carcinoma (LUSC). We analyzed the RNAseq data of PCDHGA10 to compare their expression differences. Then survival analysis, tumor microenvironment (TME) analysis, and mutation analysis were carried out. Additionally, we performed gene ontology (GO) and kyoto gene encyclopedia (KEGG) enrichment analyses to explore potential signal pathways. PCDHGA10 protein expression was evaluated using immunohistochemistry (IHC) on tissue microarrays (HLugS180Su02). By microarray analysis and database analysis, we found that PCDHGA10 was significantly highly expressed in LUSC. Sufferers with elevated PCDHGA10 levels exhibited a worse prognosis, according to the survival analysis. The PCDHGA10 mutation was also linked to LUSC patient prognosis. Besides, PCDHGA10 was closely related to tumor immune cell infiltration and immune checkpoints. In conclusion, PCDHGA10 is expected to become a new molecular marker for LUSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsBiomarkers, TumorCarcinoma, Squamous CellCadherinsHumansComputational BiologyPrognosisTumor MicroenvironmentGene Expression Regulation, NeoplasticMutationFemaleProtocadherinsMaleSurvival Analysis

Stichwörter der Autor:innen

ExpressionLung squamous cell carcinomaPCDHGA10PrognosisTumor microenvironment

Substanzen

Biomarkers, TumorCadherinsProtocadherins

Autor:innen und Institutionen

  • Xinjiang Key Laboratory of Oncology, Cancer Hospial Affiliated to Xinjiang Medical University, Urumqi, China.
  • People's Hospital of Bachu County, Xinjiang, Kashgar, China.
  • Clinical Laboratory Center, Cancer Hospial Affiliated to Xinjiang Medical University, Urumqi, China.
  • General Surgery Department, People's Hospital of Bachu County, Xinjiang, Kashgar, China.
  • Clinical Laboratory Center, Cancer Hospial Affiliated to Xinjiang Medical University, Urumqi, China. paopao1987123@163.com.

Förderung

  • Natural Science Foundation of Xinjiang Uygur Autonomous Region

Zitieren

APA

Song, S., Lu, R., Chen, Y., & Feng, Y. (2025). PCDHGA10 as a Potential Biomarker of Lung Squamous Cell Carcinoma Based on Bioinformatics and Experimental Verification. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01178-7

Vancouver

Song S, Lu R, Chen Y, Feng Y. PCDHGA10 as a Potential Biomarker of Lung Squamous Cell Carcinoma Based on Bioinformatics and Experimental Verification. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01178-7

BibTeX
@article{Song2025,
  author = {Song, Shuming and Lu, Ruijiao and Chen, Yuanya and Feng, Yangchun},
  title = {PCDHGA10 as a Potential Biomarker of Lung Squamous Cell Carcinoma Based on Bioinformatics and Experimental Verification},
  journal = {Molecular Biotechnology},
  year = {2025},
  doi = {10.1007/s12033-024-01178-7}
}
Kostenlos starten →